The legacy success of Viagra has undeniably transformed the pharmaceutical landscape. However, wagering in companies heavily dependent on generic versions and the declining patent exclusivity surrounding this flagship medication presents a notable degree of risk . While leading pharma firms might still profit from related therapies , the long-term

A thorough sector review is essential for grasping the current forces at effect. This exploration delves into major factors influencing the contested arena, from new technologies and changing consumer preferences to governmental obstacles and financial uncertainties. We’ll scrutinize the general view, including potential expansion areas, risks to